Transcranial Magnetic Stimulation for the Treatment of Chemo Brain.
Transcranial Magnetic Stimulation for the Treatment of Chemo Brain.
复制标题
DOI:
10.3390/s23198017
复制
发表时间:
2023-09-22
期刊:
影响因子:
--
通讯作者:
Chou YH
中科院分区:
文献类型:
--
作者:
Kuo PH;Chen AY;Rodriguez RJ;Stuehm C;Chalasani P;Chen NK;Chou YH
This pilot feasibility study aimed to evaluate the effects of transcranial magnetic stimulation (TMS) on chemotherapy-related cognitive impairment (CRCI), and we report here on the first patient. Background: Deleterious cognitive changes due to chemotherapy or CRCI are commonly referred to as “chemo brain”. With the increasing survival of cancer patients, this poorly understood and inadequately treated condition will likewise have an increasing toll on individuals and society. Since there is no approved treatment for chemo brain, we have initiated a therapeutic trial using transcranial magnetic stimulation (TMS), a non-invasive brain stimulation technique approved in many countries for the treatment of neurologic and psychiatric conditions like migraine and depression. Case presentation: A 58-year-old woman, diagnosed 7 years prior with left breast cancer, underwent partial mastectomy with sentinel lymph node biopsy. She then received four cycles of adjuvant chemotherapy followed by radiation therapy. Afterwards, she was on tamoxifen for 4 years and then switched to aromatase inhibitors. The patient’s CRCI started during chemotherapy and severely impaired her quality of life for an additional two years. In the third year after chemotherapy, the CRCI partially cleared to stabilize to the level at the time of presentation for this trial. The patient continues to have memory difficulties and decreased concentration, which makes multi-tasking very difficult to impossible. She is reliant on memory aids at work and at home. The participant underwent 10 consecutive sessions of TMS during weekdays for 2 weeks. Stimulation was directed to the left dorsolateral prefrontal cortex. After TMS, the participant significantly improved in memory function on neuropsychological testing. While she reported no subjective differences in concentration or memory, she did report an improvement in her sleep. Functional magnetic resonance imaging of the brain before and after TMS showed increased resting-state functional connectivity between the stimulation site and several brain regions. Remarkably, after 6 years of chemo brain and remaining in the same position at work due to her inability to concentrate and multi-task, she applied for and received a promotion 5–6 months after her TMS treatments. Conclusions: This first patient in the phase 1 clinical trial testing of TMS for the treatment of “chemo brain” provided important lessons for feasibility and insights into mechanisms of potential benefit.
登录
查看更多内容
DOI:
10.1080/13803390903032537
发表时间:
2010-01-01
影响因子:
2.2
作者:
Cimprich, Bernadine;Reuter-Lorenz, Patricia;Welsh, Robert C.
通讯作者:
Welsh, Robert C.
影响因子:
25
作者:
Gent TC;Bandarabadi M;Herrera CG;Adamantidis AR
通讯作者:
Adamantidis AR
DOI:
10.1097/jgp.0b013e31819431d5
发表时间:
2009-05
期刊:
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
影响因子:
--
作者:
Jak AJ;Bondi MW;Delano-Wood L;Wierenga C;Corey-Bloom J;Salmon DP;Delis DC
通讯作者:
Delis DC
影响因子:
--
作者:
Bai L;Yu E
通讯作者:
Yu E
影响因子:
4.7
作者:
Donovan, KA;Jacobsen, PB;McGrath, P
通讯作者:
McGrath, P